Bacterial Cell Structure and Antibiotic Mechanisms
The main objective of the research was to determine measurements of MIC value for various bacterial which are isolated and plot the data collected for the development(growth) of the bacterial to varying concentration of antibiotic; in determining the MIC of individual antibiotic from the maximum concentration to minimum at which no development was observed.
- To identify PPK inhibitor activity compounds, knowing that Gallien has PPK inhibitor activity.
- To determine the PPK activity that will be able to make bacterial more susceptible, that is: “the modified Kirby-Bauer disk diffusion susceptibility test” using the chosen assay.
- Use the indirect measurements of compound ability of organism inhabitation to establish the possible evidence of bacterial development (growth) around the disks to assure its functionality at a specific concentration.
- To use our Kwon assay to identify the type of Gallien present in disc susceptibility.
- To use the assays that have been performed to identify Gallien as PPK inhibitors.
How to perform disc susceptibility tests in the antibiotic drug discovery process?
Gram-negative bacterial have tinny cell’s walls enclosed with another lipid’s membranes called; outer membrane (O.M.). on the other hand, Gram-positive bacterial have a membrane which is cytoplasmic enclosed by cell wall which is rigid and tough. The outer membrane of Gram-negative bacterial acts as the supplementary layer of protection by preventing substances from entering the bacterium. Periplasm is the gap that separate cytoplasmic membrane from the outer membrane. These membranes have porins channels that allow drug molecules to pass through. The cell walls have a rigid layer that provides the shape of bacterium and prevent bacterial from mechanical stresses and osmosis. Cytoplasmic membranes contain flow to and FRO the cell, thus, maintaining bacterial components and cytoplasmic in defined space(Baijal and Downey, 2021, p. 21).
Cell walls of bacterial are enclosed by peptidoglycan consisting huge sugar polymer. Peptidoglycan confines crosslinking with glycan strands by peptide chains action and trans glycosidases that extends from sugars in the polymer to form crosslinks of one peptide to another. Glycine residues undergoes crosslink the D alanyl alanine portion of the peptide chain in the presence of BPs (penicillin-binding proteins). Thus, strengthening the cell’s walls of glycopeptides and Beta?lactam by inhibiting cell wall synthesis.
PBPs are the primary targets of the Beta?lactam agents. It is assumed that the Beta?lactam ring mimic the portion of D alanyl D alanine in peptide chain which PBP normally binds. The PBP interacts with the Beta?lactam ring and is not available to synthesize new peptidoglycan. The disruption of the peptidoglycan layer leads to the lysis of the bacterium.
Glycopeptide binds on the portion of D alanyl D alanine into peptide side chain of the precursor peptidoglycan subunit. The giant drug molecules of vancomycin inhibit cell’s walls synthesis by preventing the binding between PBP and D alanyl subunit.
The RNA (mRNA) transcription process uses data of bacterial DNA in the synthesize of RNA molecules. On the other hand, the translation process uses a macromolecular ribosome structure to synthesize proteins available in mRNA. Factors of cytoplasmic and ribosomes catalyze protein biosynthesis. The 70S bacterial ribosomes comprise two ribonucleoprotein subunits which are; 30S and 50S. The biosynthesis of protein is inhibited by antibacterial when it targets the 30S or 50S subunit of the bacterial ribosome inside the bacterium. They mostly target the bacterial ribosome; therefore, they must be energy-dependent for active bacterial transport mechanism when entering the bacterial cell, which needs air(oxygen) and a dynamic motive force of proton when passing the cytoplasmic membrane. Hence, AG has poor activity against anaerobic bacterial since they work in aerobic conditions. The AG synergize with antibiotic which inhibits cell’s walls synthesis like; glycopeptides and Beta?lactam since they permit the passage of A.G. through the cell at a low dosage. A.G. interacts with the 16S rRNA of the 30S subunit close to the A site by a hydrogen bond. Thus, resulting premature termination hence, misreading of mRNA translation(Bozhüyük, Micklefield, and Wilkinson, 2019, p.88).
Peptidoglycan and Cell Wall Synthesis
Tetracycline, like chlortetracycline, tetracycline, minocycline, or doxycycline, prevents tRNA from binding with A site by acting within the preserved sequence of 16S rRNA of the 30S ribosomal subunit.
The early stage of synthesizing protein is affected by translocation which targets preserved sequence of the center of peptidyl transferase in the 23S rRNA of the 50S ribosomal subunit that are caused by the premature detachment of incomplete peptide chain. The lincosamide, streptogramin B, and macrolides have same mechanisms of action.
Protein synthesis are inhibited by chloramphenicol therefore preventing the binding of tRNA in A site of the ribosomes since they interact with the conserved sequence of peptidyl transferase cavity of the 23S rRNA of the 50S subunit.
Linezolid is the newest member that has been approved of this entirely synthetic group’s novel class of antibiotics. Oxazolidinone interferes with the synthesis of protein in various phases as follows:
- binds to 23SrRNA which belongs to 50S subunit to inhibit synthesis of protein, and
- interact with peptidyl-tRNA and suppress 70S inhibition.
The DNA gyrase of bacterial enzyme is inhibited by fluoroquinolones that nick the DNA of double-stranded by introducing negative supercoil, which seals the nicked end. This is useful in preventing excess positive supercoils in the strand when they separate to allow transcription and replication. About two of both A and B subunits are contained in DNA gyrase. The subunits carry out the nicking of DNA. B subunits introduce negative supercoils, whereas A subunits reseal the strand. Fluoroquinolones interfere with strand cutting and resealing function A subunit by binding with it at high affinity. The topoisomerase (IV) is the original action target of gram-positive bacterial, which nick and separate daughter DNA strands after replication. This enzyme has a more significant relationship that confers highest potential to gram-positive bacterial. The mammal cell have topoisomerase (II), that have lowest affinity to fluoroquinolones thus, lowest toxicity to cell in place of topoisomerase IV and DNA gyrase(Cai, and Zhang, 2018, p.32).
Trimethoprim and Sulfonamides drugs inhibit distinct stages in metabolism of folic acid. when combining trimethoprim and sulpha drugs acts on different stages on similar biosynthetic pathways, indicating reduced mutation rate and synergy resistances. The dihydropteroate synthase is wholly inhibited with a higher affinity for the enzyme by Sulfonamides than the natural substrate, P aminobenzoic acid. Trimethoprim’s agent inhibits the enzyme dihydrofolate reductase by acting late in folic acid synthesis. Accumulation of antibacterial s and mechanisms of antibacterial resistance prevention from the decrease of the intake or increase the efflux of the antibacterial from the cell. Porins facilitate the outer membrane permeability to drug molecules into the cell, and its bilayer enhances self-uptake and diffusion. In gram-negative bacterial, the porin channels are located in the outer membrane. At the same time, tinny hydrophilic molecules of quinolones and Beta?lactam are located through porins and cross the outer membrane. The decreased rates of Beta?lactam antibiotics and fluoroquinolones’ entrance into the cell are due to the reduced number of porin channels. The lower permeability of all antibiotic classes in Pseudomonas aeruginosa increases the bacteria’s resistance to antibiotics(Chakraborty, 2021).
The efflux pumps are protein membranes that maintain low intracellular concentration and export antibiotics from the cell. The efflux mechanisms pump the antibiotics out of the cell and prevent them from reaching the target at the same speed that they used when entering the cell. Efflux pumps are housed in a cytoplasmic membrane. All classes of antibiotics except polymyxin are prone to activating efflux systems. Hence, they are specific to antibiotics. Many efflux pumps are multidrug-resistant organisms since they have the potential of pumping and transporting a wide variety of antibiotics such as fluoroquinolones, macrolides, and tetracyclines(Eustáquio and Ziemert, 2018.).
Penicillin-Binding Proteins and β-Lactam Antibiotics
The resistance mechanism of antibacterial to drug binding to reach the target area is caused by acquired changes and natural variations. The spontaneous mutation of a bacterial gene on the chromosome changes the target site. Minor alteration of the target molecule significantly affects antibiotic binding since antibiotic interaction with the target molecule is specific(Fazle and Baek, 2020, p.4973).
- Alterations in either 30S subunits or 50S subunits of the ribosomes lead to drug resistance, affecting proteins synthesis, that is, A.G., macrolides, chloramphenicol, and tetracycline. A.G. binds with 30S ribosomal subunits, and on the other hand, macrolides, chloramphenicol, streptogramin B, and lincosamides bind with 50S ribosomal subunits in suppressing the synthesis of proteins.
- Modification of the PBP causes alteration in PBP thus, favoring resistance mechanism in Gram-positive bacterial. And the developing of resistance to Gram-negative bacterial results to production of Beta?lactamases. The low affinity of Beta?lactam antibiotic is caused by mutation in penicillin-binding proteins. The resistance of Enterococcus faecium to Streptococcus and ampicillin pneumoniae to penicillin undergoes similar mechanism. On the other hand, staphylococcus aureus, have same resistivity to oxacillin and methicillin by genetic integration of free elements; staphylococcal cassette chromosome mec into the chromosome of S. aureus which have gene resistivity of mec A which have, PBP2A protein that is responsible in changing staphylococcal PBP. PBP2A have higher resistivity to Beta?lactam antibiotic. S. aureus have cross-resistant to streptomycin, erythromycin, tetracycline, all Beta?lactam antibiotic.
- Alteration of cell wall precursor: glycopeptides inhibits cell’s walls synthesis by binding to D alanyl D alanine residues of peptidoglycan precursors in Gram-positive bacterial, for example, in teicoplanin or vancomycin. Glycopeptides do not crosslink with D alanyl alanine, changing it to D alanyl lactate. Thus, developing high resistance(Van A?type resistance) to teicoplanin and vancomycin caused by Enterococcus faecalis and E. faecium and strains. The resistances are less sensitive to vancomycin but more sensitive to teicoplanin on type Van C and B.
- Fluoroquinolone’s resistivity is caused by topoisomerase and mutated?DNA gyrase: Quinolone binds to DNA gyrases of subunit A. The mechanisms of resistance involve the modification of two enzymes; that is, topoisomerase of part C and part E gene and DNA gyrase of gyr A and gyr B gene. the mutation in gene par C and gyr A results in failure in replication(binding) which is caused by fluoroquinolones.
- Ribosomal protection mechanisms cause tetracyclines resistance.
- Resistance to rifampicin is established by mutation of RNA polymerase.
The antibiotic are inactivated by three major enzymes: chloramphenicol acetyltransferases (AACs), aminoglycoside modifying enzymes, and Beta?lactamases.
A.G. has poor activity against anaerobic bacterial since they work in aerobic conditions. The AG synergize with antibiotic which inhibits cell’s walls synthesis like; glycopeptides and Beta?lactam since they permit the passage of A.G. through the cell at a low dosage. A.G. interacts with the 16S rRNA of the 30S subunit close to the A site by a hydrogen bond. Thus, resulting premature termination hence, misreading of mRNA translation Protein synthesis are inhibited by chloramphenicol therefore preventing the binding of tRNA in A site of the ribosomes since they interact with the conserved sequence of peptidyl transferase cavity of the 23S rRNA of the 50S subunit(Greco, Keller, and Rokas, 2019, p.22).
PBPs are the major targets of the Beta?lactam agents. It is assumed that the Beta?lactam ring mimic the portion of D alanyl D alanine in peptide chain which PBP normally binds. The PBP interacts with the Beta?lactam ring and is not available to synthesize new peptidoglycan. The disruption of the peptidoglycan layer leads to the lysis of the bacterium. The Beta?lactamases are preventive enzymes and are grouped using two major grouping systems: functional and structural. The classification by structural(Ambler)
- The class A Beta?lactamases: are also called clavulanic acid susceptible or penicillinase. SHV?1 and TEM?1 are Class A Beta?lactamases of Enterobacteriaceae members. They are penicillinase having fewer activities against cephalosporin. They are progenitors called ESBL (extended spectrum Beta?lactamases). These enzymes have altered their substrate profile due to the substitution of amino acids permitting the hydrolysis of most cephalosporins. The extended-spectrum Beta?lactamases are inhibited by Beta?lactamases inhibitors like; tazobactam, clavulanic acid, or sulbactam, sensitive to methoxy cephalosporins(carbapenems and cephamycin) and they resist third-generation cephalosporins(cefotaxime, ceftriaxone, ceftazidime); penicillin; aztreonam; cefoperazone; and cefamandole.
- The class B Beta?lactamases are metallo Beta?lactamases; they require catalysis enzymes like heavy metals or zinc and chelating agents to inhibit their activities. These enzymes resist carbapenems, clavulanate, aztreonam, and sulbactam inactivation’s like, New Delhi Metallo Beta?lactamase.
- The class C Beta?lactamases are called cephalosporinases. All Gram-negative bacterial produce them apart from, Klebsiella and Salmonella. They hydrolyze cephalosporins when compared to class A Beta?lactamases. They can bind the bulky extended-spectrum penicillin since of their huge cavities. Amp C Beta?lactamases are example of class C Beta?lactamases. They are not inhibited by clavulanate and are resistant to all Beta?lactam and not to carbapenems.
- The class D Beta?lactamases are oxacillin hydrolyzing enzymes that exists in aeruginosa and Enterobacteriaceae. clavulanic acid have weak inhabitation on them but are inhibited by sodium chloride and resistant to cloxacillin, penicillin, methicillin, and oxacillin(Hemmerling, and Piel, 2022, p.1).
In the past twenty years, the effectiveness of polyphosphate for P. aeruginosa virulence was discovered from the pioneer task of late Nobel laureate Arthur Kornberg. The discovery of an effective antibacterial drug was crucial in better treating bacterial infections. In this case, polyphosphate is critical since its antibiotic tolerance, stress response, and P. aeruginosa virulence, thus, indicating better results when used in antibiotic to target microbial. For the first time using antibiotic treatments, small molecules of Gallein distracts polyP (polyphosphate) in agents; they inhibit PPK1 and PPK2 (PPKs families) which contains P. aeruginosa by showing dual susceptibility when inhibiting PPK. During inhibitor treatment, the phenocopies of PPKs are deleted, resulting in a reduction of cellular accumulation of polyphosphate by forming attenuated biofilm, pyoverdine, motility, and pyocyanin. The Gallein synergized with antibiotic and caused Caenorhabditis elegans infection to attenuate P. aeruginosa virulence by exhibiting negligible toxicity on HEK293T cells and nematodes, hence, indicating that PPK inhibitors are the reference point to drug discovery(Hug, Panter, Krug, and Müller, 2019, p.319).
Both PPK1 and PPK2 enzymes are encoded by P. aeruginosa in bacterial pathogens to maintain polyphosphate homeostasis. The PPKs have distinct catalytic mechanisms and structures, but they can consume and synthesize polyphosphate. In this case, PPK2 enzymes can compensate for losses in PPK1. The research established that small molecules of Gallein distract polyP (polyphosphate) in agents; they inhibit PPK1 and PPK2 (PPKs families), which contain P. aeruginosa by showing dual susceptibility when inhibiting PPKs. During inhibitor treatment, the phenocopies of PPK are deleted and therefore, resulting in the reduction of cellular accumulation of polyphosphate in DPPK1, DPPK2, and wild type (W.T.) strains to levels of DPPK1, DPPK2A, DPPK2B and DPPK2C in knockout control, forming attenuated biofilm, pyoverdine, motility, and pyocyanin. The Gallein synergized with antibiotic and caused Caenorhabditis elegans infection to attenuate P. aeruginosa virulence by exhibiting negligible toxicity on HEK293T cells and nematodes, hence, indicating that PPK inhibitors are the reference point for treatments(Kang, and Wang, 2020, p.1562.).
Ribosomes and Protein Synthesis Inhibition
It is established that PPK2 and PPK1 are valuable drug targets in P. aeruginosa, hence, indicating that PPK inhibitors are the reference point for drug discovery. The linear polymer of inorganic phosphate residues ranging from about one thousand monomers in length forms Inorganic polyphosphate. PPK1 and PPK2 (PPKs families) enzymes synthesize and consume polyphosphate in the bacterial. PPK1 enzyme catalyzes polyphosphate synthesis by ATP, a phosphor donor. At the same time, the PPK2 enzyme destroys polyphosphate to phosphorylate nucleotides; established by Nobel Arthur Kornberg. PPK1 is an essential determinant for virulence in P. Aeruginosa. Since, during inhibitor treatment, the phenocopies of PPK are deleted, resulting in the reduction of cellular accumulation of polyphosphate by forming attenuated biofilm, pyoverdine, motility, and pyocyanin in relevant pathogens, comprising Campylobacter jejune, Escherichia coli, Francisella tularensis, Proteus mirabilis and Mycobacterium tuberculosis. PPKs families’ enzymes have potential targets for antibacterial therapeutics by establishing their various inhibitors, but in compounds, low nanomolar activity or micromolar against PKKs classes have not been found (Khabthani, Rolain, and Merhej, 2021, p.2297).
The inhibitors targeting PPK1 and PPK2 (PPKs families) enzymes can provide the best therapeutic options due to high bacterial pathogens priorities like Klebsiella, P. aeruginosa, pneumoniae, Acinetobacter Baumann, C. jejune, and F. tuberculosis consists a minimum of one of PPKs. The P. aeruginosa genome is encoded by PPK1, PPK2A, three PPK2 enzymes, PPK2C and PPK2B. The PPK2B and PPK2A of P. aeruginosa generate sufficient polyphosphate to form granules as a supplementary of PPK1 inactivation. At the same time, PPK2A facilitates exit for the near-normal cell cycle. During inhibitor treatment, the phenocopies of PPK are deleted, resulting in the reduction of cellular accumulation of polyphosphate by forming attenuated biofilm, pyoverdine, motility, and pyocyanin. The Gallein synergized with antibiotic and caused Caenorhabditis elegans infection to attenuate P. aeruginosa virulence by exhibiting negligible toxicity on HEK293T cells and nematodes, hence, indicating that PPK inhibitors are the reference point to drug discovery as directed by World Health Organization(Larsen, Pearson, and Neilan, 2021, p.56).
Pyoverdine in P. aeruginosa is the principal of siderophore, which serves to import and chelate iron into the bacterial cell. It leads to the formation of distinctive green color during the culture of P. aeruginosa. The phenocopies of PPK are deleted, resulting in a reduction of cellular accumulation of polyphosphate by forming attenuated biofilm, pyoverdine, motility, and pyocyanin. The Gallein synergized with antibiotic and caused Caenorhabditis elegans infection to attenuate P. aeruginosa virulence by exhibiting negligible toxicity on HEK293T cells and nematodes. Genetic and phenotype analysis are used in the determination of mutation and bacterial resistance to antibiotic respectively. This is essential to health practitioners when establishing the best antibiotic to give patients(Milke, and Marienhagen, 2020, p.6057).
In this study, P. aeruginosa, for PPKs enzymes, is an ant virulence target when purified and expressed in PPK1, PPK2A, PPK2B, and PPK2C in biochemical research. Using analog synthesis and compound screening new family of polyhydroxylated is identified as small molecules of Gallein distract polyP (polyphosphate) in agents; they inhibit PPK1 and PPK2 (PPKs families), which contains P. aeruginosa by showing dual susceptibility when inhibiting PPKs. During inhibitor treatment, the phenocopies of PPK are deleted, resulting in a reduction of cellular accumulation of polyphosphate by forming attenuated biofilm, pyoverdine, motility, and pyocyanin(Scott, and Piel, 2019, p.404).
Fluoroquinolones and DNA Damage Prevention
When conducting Gallein distracts polyP (polyphosphate) in agents, they inhibit PPK1 and PPK2 (PPKs families), which contain P. aeruginosa by showing dual susceptibility when inhibiting PPK. During inhibitor treatment, the phenocopies of PPKs are deleted and therefore, resulting in the reeducation of cellular accumulation of polyphosphate by forming attenuated biofilm, pyoverdine, motility, and pyocyanin. The Gallein synergized with antibiotic and caused Caenorhabditis elegans infection to attenuate P. aeruginosa virulence by exhibiting negligible toxicity on HEK293T cells and nematodes, hence, indicating that PPKs inhibitors provide a foundation for the future design discovery and development of new antibiotic drug(Silva, Blom, Keller?Costa and Costa, 2019, p.4002).
Past research has shown that PPKs families’ enzymes have potential targets for antibacterial therapeutics by establishing their various inhibitors. Still, compounds with low nanomolar activity or micromolar against PKKs classes have not been shown. There, creating room for developing disc susceptibility inhibitors that act on all types of enzymes using an attractive methodology. This is made possible by using RT1 and ellagic acid as a reference point to synthesize compounds that can hit Gallein compounds that inhibit PPK1, PPK2B, and PPK2A at low micromolar concentration. The PKK’s enzymes are catalyzed under the same chemical reactions since they have similar structural homology and sequence. PPK2 enzymes are minor thirty-five kDa. It shares mechanistic and structural similarities with thymidylate kinases; here, walkers A and B fill the position where the nucleotide substrate of Mg21 is catalyzed to perform a nucleophilic attack on the terminal phosphate of polyphosphate. Whereas PPK1 enzymes are large, about seventy-five kDa, it shares mechanistic and structural similarities with the phospholipase D family of proteins when catalyzed by phosphohistidine. Still, the research suggests that Gallein acts as a nucleotide mimetic in static binding sites for PKKs enzymes classes. The weakness of inhibition of PPK2C by Gallein is due to catalyzing of class II PPK2 enzymes to change nucleoside of monophosphates into nucleoside diphosphates. PPK2A and PPK2B belong to class I enzymes that catalyze phosphorylate nucleosides into diphosphates. The structural comparisons of PPK2 (class I) and Meiothermus rubber PPK2 (class III) of F. tuberculosis phosphorylate into diphosphates or nucleoside mono. Its distinct nucleotide-binding orientations identify this. Adenosine moiety is mainly shifted to M. rubber protein. Thus, PPK2C has less impact on static binding sites of Gallein. Therefore, the structural similarity of NSC 9037 and Gallein suggests the best inhibitor results of M. tuberculosis PPK2, which is a Galleon-based inhibitor that can be used in combating PKK2 bacterial pathogens carriers (Zhang, Sun, Wang, Chen, Xue, Zhang, Zhu, Duan, and Yan, 2021, p.1).
List of compounds for testing against Gallein
Rupesh
EMC1059 B3
EMC1059 D5
Mohammed
BU10016 (EMC1059D3)
EMC1048
Ahsan
BU10078
EMC1041
Dozen
BU10009 (EMC1058C1)
EMC1058C3
Aruna
BU10004
EMC1085M3
Manor
BU10007 (EMC1058B2)
EMC1058L1
Lama
BU10077 (EMC1092NI)
EMC1051
Viviene
BU10067 (EMC1085MI)
EMC1085L3
Said
BU10003 EMC1058A2
EMC 1080
The plates were set up by making stocks of each three bacterial at an absorbance at 600 nm of 0.05. fill strips of 8 wells with 180 ul of bacterial either singly or in duplicate or triplicate; for each row, this means 8 x 180 ul = 1440 ul (so effectively 5 MLS for three rows). Provide for a control row having no addition of antibiotic to check for growth, although typically, this should not be needed for the lowest dilution of antibiotic still allows development. Make a thick stock of each bacterium by scraping colonies from the plate or growing stock in the media for a few hours. In obtaining the desired absorbance of about 0.05, dilute and fill the test plates. Begin by measuring the absorbance with bacterial stock using a spectrometer set to 600 nm using a blank of L.B. media.
Folic Acid Metabolism and Trimethoprim-Sulfamethoxazole
The computation of the amount of stock required is given as:
The volume of dense stock =
Then, add the media to the final total volume obtained(this was done for each bacterial test).
The setup of the serial dilutions of the antibiotic to be tested was done as follows. The test required the setup of 4 sets, each having 8 Eppendorf tubes (1.5ml tubes) and one set for each of the antibiotic. A 2-fold serial dilution was then made from a 4-fold series to give a more considerable range of dilutions by changing the volumes of water in each tube to 450 ul, and the volume transferred to 150 ul by making up enough diluted antibiotic for several plates (300 ul of diluted antibiotic in each tube). More samples were done by adjusting the volumes as 3 x 20 ul per bacterial for each measurement in triplicate. The four sets of eight tubes were placed in a rack; each group was labeled from one to eight, as demonstrated below:
- Fill all of the tubes apart from the first one of each set with 300 ul of water.
- Makeup to 600 ul of antibiotic concentration to begin within the test for the first tube of each set.
- Transfer about 300 ul into the second tube from the first tube, then mix it. Then, transfer 300 ul to the third from the second tube, and mix it. Repeat the above, moving 300 ul from each tube to the next until the last tube. To obtain sets of serial dilutions to test than required to complete this for all four antibiotic tests.
- Then add about 20ul of each serial dilution to set up the antibiotic test from the most dilute to highest concentration to the 8th to first columns on the microplate. Do not change tips as filled in each row by filling this order. Fill one row at a time for each of the four antibiotic.
- Add 180 ul of stock across four rows of wells and fill the set of wells to test with bacterial from the stocks made., using a new tip for each row. The figure below shows the summary of how to make serial dilution.
After setting up the plates, the measurement was done from the initial absorbance in the microplate reader was obtained by ensuring the reader is set to 600 nm and readings of the absorbance for the plate made. The uniformity in absorbance across all wells was observed, implying that the setup of plates was correct. The plate was then incubated at 37 C for at least 3 hours to let the cells grow to repeat the measurements to determine if the cells had grown. Plot results of absorbance versus dilution to determine the lowest concentration needed to inhibit the cells and MIC(Minimum Inhibitory Concentration).
- use a sterile to inoculate, needle or loop, and touch four or five isolated colonies of the organism to be tested.
- Using sterile falcon tubes, suspend the organism containing 5 mL of L.B. Broth.
- Incubate bacterial overnight in a shaker incubator at 37°C and record the OD600nm should be 1.0 x 109 cells ml-1
- Dilute overnight culture broths 1 in 10 using sterile Eppendorf tubes and read the O.D. at 600 nm, expected to have 1.0 x 108 cells ml-1.
- Using a sterile spreader, from the 107 concentrations of O/N broth with different strains, take 100 µl and spread onto M.H. agar plates.
- The same procedure can be used for each broth strain onto M.H. agar plates.
- Allow inoculated plates to dry for 30 minutes at room temperature.
The disc susceptibility of Gallein distracts polyP (polyphosphate) in agents; they inhibit PPK1 and PPK2 (PPKs families), which contain P. aeruginosa by showing dual susceptibility when inhibiting PPK. During inhibitor treatment, the phenocopies of PPKs are deleted and therefore, resulting in a reduction of cellular accumulation of polyphosphate in DPPK1, DPPK2, and wild type (W.T.) strains to levels of DPPK1, DPPK2A, DPPK2B and DPPK2C in knockout control, forming attenuated biofilm, pyoverdine, motility, and pyocyanin. The Gallein synergized with antibiotic and caused Caenorhabditis elegans infection to attenuate P. aeruginosa virulence by exhibiting negligible toxicity on HEK293T cells and nematodes, hence, indicating that PPKs inhibitors are the reference point for treatments. It is established that PPK2 and PPK1 are valuable drug targets in P. aeruginosa, therefore, implying that PPK inhibitors are the reference point for drug discovery. The linear polymer of inorganic phosphate residues ranging from about one thousand monomers in length forms Inorganic polyphosphate. PPK1 and PPK2 (PPKs families) enzymes synthesize and consume polyphosphate in the bacterial. PPK1 enzyme catalyzes polyphosphate synthesis by ATP, a phosphor donor. Glycopeptides inhibit cell wall synthesis by binding to D alanyl D alanine residues of peptidoglycan precursors in Gram-positive bacterial, for example, in teicoplanin or vancomycin. Glycopeptides do not crosslink with D alanyl alanine, changing it to D alanyl lactate. Thus, developing high resistance(Van A?type resistance) to teicoplanin and vancomycin caused by Enterococcus faecalis and E. faecium and strains. The resistances are less sensitive to vancomycin but more sensitive to teicoplanin on type Van B and C resistance.
Pyoverdine in P. aeruginosa is the principal of siderophore, which serves to import and chelate iron by reaction inhibitor in E. coli into the bacterial cell. The phenocopies of PPK are deleted, resulting in a reduction of cellular accumulation of polyphosphate by forming attenuated biofilm, pyoverdine, motility, and pyocyanin. The Gallein synergized with antibiotic and caused Caenorhabditis elegans infection to attenuate P. aeruginosa virulence by exhibiting negligible toxicity on nematodes. The determination of bacterial resistance to antibiotic of all classes; phenotypes and mutations responsible for bacterial resistance to antibiotic.
Motility caused by flagellar requires the critical establishment of its acute infections, which is compromised by Gallein treatments in a pink-dependent fashion, with previous corroborating reports linking polyphosphate to this phenotype in P. aeruginosa. Once again, our results show that deletion of all four pink genes or treatment with Both PPK1 and PPK2 enzymes are encoded by P. aeruginosa in bacterial pathogens to maintain polyphosphate homeostasis. The PPKs have distinct catalytic mechanisms and structures, but they can consume and synthesize polyphosphate. In this case, PPK2 enzymes can compensate for losses in PPK1. The research established that small molecules of Gallein distract polyP (polyphosphate) in agents; they inhibit PPK1 and PPK2 (PPKs families), which contain P. aeruginosa by showing dual susceptibility when inhibiting PPK. During inhibitor treatment, the phenocopies of PPK are deleted and therefore, resulting in a reduction of cellular accumulation of polyphosphate in DPPK1, DPPK2, and wild type (W.T.) strains to levels of DPPK1, DPPK2A, DPPK2B and DPPK2C in knockout control, forming attenuated biofilm, pyoverdine, motility, and pyocyanin. The Gallein synergized with antibiotic and caused Caenorhabditis elegans infection to attenuate P. aeruginosa virulence by exhibiting negligible toxicity in the cell. Inhibiting PPK1 and PPK2 enzymes values are supported in C. elegans models of disease for S.K. and L.K. assays in Gallein treatment of wild type. P. aeruginosa phenocopied attenuates the virulence of the D polyphosphate strain. P. aeruginosa pathogenesis is used in L.K. to mediate and reduce pyoverdine levels in D polyphosphate cells and galleon treatment when Gallein is combined with ciprofloxacin and antibiotic tetracycline, it synergetic protection of C. elegans in L.K.
Gallein shows inhibitors in mammalian C. elegans and G protein-coupled receptors (GPCRs), referred to as OCTR1. They are used in innate immunity in targeting Gallein. But in the absence of additives, the P. aeruginosa strain is effective in treating infections in C. elegans with D polyphosphate compared to the wild-type strain due to off-target OCTR1 inhibitors.
PPK2 and PPK1 are valuable drug targets in P. aeruginosa, indicating that PPK inhibitors are the reference point for drug discovery. The linear polymer of inorganic phosphate residues ranging from about one thousand monomers in length forms Inorganic polyphosphate. PPK1 and PPK2 (PPKs families) enzymes synthesize and consume polyphosphate in the bacterial. PPK1 enzyme catalyzes polyphosphate synthesis by ATP, a phosphor donor. In contrast, the PPK2 enzyme destroys polyphosphate to phosphorylate nucleotides; established by Nobel Arthur Kornberg. PPK1 is an essential determinant for virulence in P. Aeruginosa. Since, during inhibitor treatment, the phenocopies of PPK are deleted, resulting in the reduction of cellular accumulation of polyphosphate by forming attenuated biofilm, pyoverdine, motility, and pyocyanin in relevant pathogens, comprising Campylobacter jejune, Escherichia coli, Francisella tuberculosis, Proteus mirabilis and Mycobacterium tuberculosis. PPKs families’ enzymes have potential targets for antibacterial therapeutics by establishing their various inhibitors.
Conclusion
Drug discovery for antibiotic is a great relief; the prolonged use of antibiotic causes the emergence of new infections. The use of antibiotic drugs to treat bacterial over a long time makes some bacterial more resistant and competitive to resist antibacterial drugs. The resistance of bacterial to antibacterial is a critical problem when it comes to treating microbial infections. These biochemicals resistance mechanisms to antibacterial are; target modification, antibiotic inactivation, relief of metabolic pathway, and altered permeability. The bacterial phenotypes and mutations are the leading cause of bacterial resistance to antibiotic. Therefore, research on establishing bacterial phenotypes and genetic analysis are essential in determining bacteria’s antibiotic resistance. Genetic and phenotype analysis are used in the determination of mutation and bacterial resistance to antibiotic respectively. This is essential to health practitioners when establishing the best antibiotic to give patients.
PPKs families’ enzymes have potential targets for antibacterial therapeutics by establishing their various inhibitors, but in compounds, low nanomolar activity or micromolar against PKKs classes have not been established. Therefore, future research will be based on discovering the inhabitancy of compounds with low nanomolar activities and micromolar.
References
Akbar, A., Prince, C., Payne, C., Fasham, J., Ahmad, W., Maple, E.L., Crosby, A.H., Harlalka, G.V., and Gul, A., 2019. Novel nonsense variants in SLURP1 and DSG1 cause palmoplantar keratoderma in Pakistani families. BMC medical genetics, 20(1), pp.1-7. Retrieved from: https://bmcmedgenet.biomedcentral.com/articles/10.1186/s12881-019-0872-1
Alanjary, M., Cano-Prieto, C., Gross, H. and Medema, M.H., 2019. Computer-aided re-engineering of nonribosomal peptide and polyketide biosynthetic assembly lines. Natural Product Reports, 36(9), pp.1249-1261. Retrieved from: https://pubs.rsc.org/en/content/articlehtml/2019/np/c9np00021f
Alihodži?, S., Bukvi?, M., Elenkov, I.J., Hutinec, A., Koštrun, S., Peši?, D., Saxty, G., Tomaškovi?, L. and Žiher, D., 2018. Current trends in macrocyclic drug discovery and beyond-Ro5. Progress in Medicinal Chemistry, 57, pp.113-233. Retrieved from: https://www.sciencedirect.com/science/article/pii/S007964681830002X
Atanasov, A.G., Zotchev, S.B., Dirsch, V.M. and Supuran, C.T., 2021. Natural products in drug discovery: advances and opportunities. Nature Reviews Drug Discovery, 20(3), pp.200-216. Retrieved from: https://www.nature.com/articles/s41573-020-00114-z
Avalos, J. and Limón, M.C., 2021. Fungal Secondary Metabolism. Encyclopedia, 2(1), pp.1-13. Retrieved from: https://www.mdpi.com/2673-8392/2/1/1
Bagde, S.R., Mathews, I.I., Fromme, J.C. and Kim, C.Y., 2021. Modular polyketide synthase contains two reaction chambers that operate asynchronously. Science, 374(6568), pp.723-729. Retrieved from: https://www.science.org/doi/abs/10.1126/science.abi8532
Baijal, K. and Downey, M., 2021. Targeting Polyphosphate Kinases in the Fight against Pseudomonas aeruginosa. M, 12(4), pp.e01477-21. Retrieved from: https://journals.asm.org/doi/abs/10.1128/mBio.01477-21
Bozhüyük, K.A., Micklefield, J. and Wilkinson, B., 2019. Engineering enzymatic assembly lines to produce new antibiotic. Current opinion in microbiology, 51, pp.88-96. Retrieved from: https://www.sciencedirect.com/science/article/pii/S1369527419300268
Brown, D., Kim, H.S., McGovern, A., Probyn, C. and Proctor, R.H., Genus-Wide Analysis of Fusarium Polyketide Synthases Reveals Broad Chemical Potential. Available at SSRN 4001455. Retrieved from: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4001455
Cai, W. and Zhang, W., 2018. Engineering modular polyketide synthases for the production of biofuels and industrial chemicals. Current opinion in biotechnology, 50, pp.32-38. Retrieved from: https://www.sciencedirect.com/science/article/pii/S0958166917301490
Chakraborty, P., 2021. Gene cluster from plant to microbes: Their role in genome architecture, organism’s development, specialized metabolism, and drug discovery. Biochimie. Retrieved from: https://www.sciencedirect.com/science/article/pii/S0300908421002728
Charfeddine, C., Dallali, H., Abdessalem, G., Ghedira, K., Hamdi, Y., Elouej, S., Landoulsi, Z., Delague, V., Lagarde, A., Levy, N. and El-Amraoui, A., 2020. Identification of a CDH12 potential candidate genetic variant for an autosomal dominant form of transgressions and progressions palmoplantar keratoderma in a Tunisian family. Journal of Human Genetics, 65(4), pp.397-410. Retrieved from: https://www.nature.com/articles/s10038-019-0711-4
Chen, H., Bian, Z., Ravichandran, V., Li, R., Sun, Y., Huo, L., Fu, J., Bian, X., Xia, L., Tu, Q., and Zhang, Y., 2019. Biosynthesis of polyketides by trans-AT polyketide synthases in Burkholderiales. Critical Reviews in Microbiology, 45(2), pp.162-181. Retrieved from: https://www.tandfonline.com/doi/abs/10.1080/1040841X.2018.1514365
Elsaeed, E., Enany, S., Hanora, A. and Fahmy, N., 2020. Comparative metagenomic screening of aromatic hydrocarbon degradation and secondary metabolite-producing genes in the Red Sea, the Suez Canal, and the Mediterranean Sea. OMICS: A Journal of Integrative Biology, 24(9), pp.541-550. Retrieved from: https://www.liebertpub.com/doi/abs/10.1089/omi.2020.0070
Eustáquio, A.S. and Ziemert, N., 2018. Identification of natural product biosynthetic gene clusters from bacterial genomic data. Retrieved from: Retrieved from: https://link.springer.com/protocol/10.1007/7653_2018_32
Fazle Rabbee, M. and Baek, K.H., 2020. antibacterial activities of lipopeptides and polyketides of Bacillus velezensis for agricultural applications. Molecules, 25(21), p.4973. Retrieved from: https://www.mdpi.com/871136
Greco, C., Keller, N.P. and Rokas, A., 2019. Unearthing fungal chemodiversity and prospects for drug discovery. Current opinion in microbiology, 51, pp.22-29. Retrieved from: https://www.sciencedirect.com/science/article/pii/S1369527418301437
Heinilä, L.M.P., Fewer, D.P., Jokela, J.K., Wahlsten, M., Ouyang, X., Permi, P., Jortikka, A. and Sivonen, K., 2021. The Structure and biosynthesis of heinamides A1–A3 and B1–B5, antifungal members of the Laxaphycin lipopeptide family. Organic & biomolecular chemistry, 19(25), pp.5577-5588. Retrieved from: https://pubs.rsc.org/en/content/articlehtml/2021/ob/d1ob00772f
Helfrich, E.J., Ueoka, R., Chevrette, M.G., Hemmerling, F., Lu, X., Leopold-Messer, S., Minas, H.A., Burch, A.Y., Lindow, S.E., Piel, J. and Medema, M.H., 2021. Evolution of combinatorial diversity in trans-acyltransferase polyketide synthase assembly lines across bacteria. Nature communications, 12(1), pp.1-14. Retrieved from: https://www.nature.com/articles/s41467-021-21163-x
Helfrich, E.J., Vogel, C.M., Ueoka, R., Schäfer, M., Ryffel, F., Müller, D.B., Probst, S., Kreuzer, M., Piel, J. and Vorholt, J.A., 2018. Bipartite interactions, antibiotic production and biosynthetic potential of the Arabidopsis leaf microbiome. Nature microbiology, 3(8), pp.909-919. Retrieved from: https://www.nature.com/articles/s41564-018-0200-0
Hemmerling, F. and Piel, J., 2022. Strategies to access biosynthetic novelty in bacterial genomes for drug discovery. Nature Reviews Drug Discovery, pp.1-20. Retrieved from: https://www.nature.com/articles/s41573-022-00414-6
Hug, J.J., Panter, F., Krug, D. and Müller, R., 2019. Genome mining reveals uncommon alkylpyrones as type III PKS products from myxobacteria. Journal of Industrial Microbiology and Biotechnology, 46(3-4), pp.319-334. Retrieved from: https://academic.oup.com/jimb/article-abstract/46/3-4/319/5997217
Kang, J. and Wang, Z., 2020. Mut9p-LIKE KINASE family members: New roles of the plant-specific casein kinase I in plant growth and development. International journal of molecular sciences, 21(5), p.1562. Retrieved from: https://www.mdpi.com/649962
Kapoor, N., Bhardwaj, R. and Gambhir, L., 2022. Chemical Diversity in Fungi: Strategies to Mitigate antibacterial Resistance. In Emerging Modalities in Mitigation of antibacterial Resistance (pp. 333-356). Springer, Cham. Retrieved from: https://link.springer.com/chapter/10.1007/978-3-030-84126-3_14
Keller, N.P., 2019. Fungal secondary metabolism: regulation, function and drug discovery. Nature Reviews Microbiology, 17(3), pp.167-180. Retrieved from: https://www.nature.com/articles/s41579-018-0121-1
Khabthani, S., Rolain, J.M. and Merhej, V., 2021. In silico/in vitro strategies led to discovery of new nonribosomal peptide and polyketide antibiotic active against human pathogens. Microorganisms, 9(11), p.2297. Retrieved from: https://www.mdpi.com/2076-2607/9/11/2297
Khan, M.I., Choi, S., Zahid, M., Ahmad, H., Ali, R., Jelani, M. and Kang, C., 2018. Whole-exome sequencing analysis reveals a COL20A1 missense mutation co-segregation in a Pakistani family with striate palmoplantar keratoderma. Genes & genomics, 40(7), pp.789-795. Retrieved from: https://link.springer.com/article/10.1007/s13258-018-0695-z
Kim, W., Liu, R., Woo, S., Kang, K.B., Park, H., Yu, Y.H., Ha, H.H., Oh, S.Y., Yang, J.H., Kim, H. and Yun, S.H., 2021. Linking a gene cluster to atranorin, a significant cortical substance of lichens, through genetic dereplication and heterologous expression. MBio, 12(3), pp.e01111-21. Retrieved from: https://journals.asm.org/doi/abs/10.1128/mBio.01111-21
Larsen, J.S., Pearson, L.A. and Neilan, B.A., 2021. Genome mining and evolutionary analysis reveal diverse type III polyketide synthase pathways in cyanobacteria. Genome Biology and Evolution, 13(4), p.evab056. Retrieved from: https://academic.oup.com/gbe/article-abstract/13/4/evab056/6178795
Latorre-Estivalis, J.M., Almeida, F.C., Pontes, G., Dopazo, H., Barrozo, R.B. and Lorenzo, M.G., 2021. Evolution of the insect PPK gene family. Genome biology and evolution, 13(9), p.evab185. Retrieved from: https://academic.oup.com/gbe/article-abstract/13/9/evab185/6352500
Liang, H., Jiang, L., Jiang, Q., Shi, J., Xiang, J., Yan, X., Zhu, X., Zhao, L., Shen, B., Duan, Y. and Huang, Y., 2019. A 3?hydroxy?3?methylglutaryl?CoA synthase?based probe for the discovery of the acyltransferase?less type I polyketide synthases. Environmental Microbiology, 21(11), pp.4270-4282. Retrieved from: https://sfamjournals.onlinelibrary.wiley.com/doi/abs/10.1111/1462-2920.14787
Mahapatra, G.P., Raman, S., Nayak, S., Gouda, S., Das, G. and Patra, J.K., 2020. Metagenomics approaches in discovering and developing new bioactive compounds from marine actinomycetes. Current microbiology, 77(4), pp.645-656. Retrieved from: https://link.springer.com/article/10.1007/s00284-019-01698-5
Malovitski, K., Sarig, O., Assaf, S., Mohamad, J., Malki, L., Bergson, S., Peled, A., Eskin-Schwartz, M., Gat, A., Pavlovsky, M. and Sprecher, E., 2022. Loss-of-function variants in KLF4 underlie autosomal dominant palmoplantar keratoderma. Genetics in Medicine. Retrieved from: https://www.sciencedirect.com/science/article/pii/S1098360022000259
Milke, L. and Marienhagen, J., 2020. Engineering intracellular malonyl-CoA availability in microbial hosts and its impact on polyketide and fatty acid synthesis. Applied microbiology and biotechnology, 104(14), pp.6057-6065. Retrieved from: https://link.springer.com/article/10.1007/s00253-020-10643-7
Minas, H.A., 2022. Towards Engineering trans-Acyltransferase Polyketide Synthases (Doctoral dissertation, ETH Zurich). Retrieved from: https://www.research-collection.ethz.ch/bitstream/handle/20.500.11850/536728/6/Abstract_28113.pdf
Morishita, Y., Zhang, H., Taniguchi, T., Mori, K., and Asai, T., 2019. The discovery of fungal polyene macrolides via a postgenomic approach reveals a polyketide macrocyclization by trans-acting thioesterase in fungi. Organic Letters, 21(12), pp.4788-4792. Retrieved from: https://pubs.acs.org/doi/abs/10.1021/acs.orglett.9b01674
Neville, N., Roberge, N., Ji, X., Stephen, P., Lu, J.L., and Jia, Z., 2021. A dual-specificity inhibitor targets polyphosphate kinase 1 and 2 enzymes to attenuate the virulence of Pseudomonas aeruginosa. M, 12(3), pp.e00592-21. Retrieved from: https://journals.asm.org/doi/abs/10.1128/mBio.00592-21
Nivina, A., Paredes, S.H., Fraser, H.B. and Khosla, C., 2021. GRINS: Genetic elements that recode assembly-line polyketide synthases and accelerate their diversification. Proceedings of the National Academy of Sciences, 118(26). Retrieved from: https://www.pnas.org/content/118/26/e2100751118.short
Nivina, A., Paredes, S.H., Fraser, H.B. and Khosla, C., 2021. INAUGURAL ARTICLE by a Recently Elected Academy Member: GRINS: Genetic elements that recode assembly-line polyketide synthases and accelerate their diversification. Proceedings of the National Academy of Sciences of the United States of America, 118(26). Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256042/
Nivina, A., Yuet, K.P., Hsu, J. and Khosla, C., 2019. Evolution and Diversity of Assembly-Line Polyketide Synthases: Focus Review. Chemical Reviews, 119(24), pp.12524-12547. Retrieved from: https://pubs.acs.org/doi/abs/10.1021/acs.chemrev.9b00525
Nofiani, R., Philmus, B., Nindita, Y. and Mahmud, T., 2019. 3-Ketoacyl-ACP synthase (KAS) III homologs and their roles in natural product biosynthesis. MedChemComm, 10(9), pp.1517-1530. Retrieved from: https://pubs.rsc.org/en/content/articlehtml/2019/md/c9md00162j
Pidot, S.J. and Rizzacasa, M.A., 2020. The Nargenicin Family of Oxa?Bridged Macrolide antibiotic. Chemistry-A European Journal, 26(13), pp.2780-2792. Retrieved from: https://chemistry-europe.onlinelibrary.wiley.com/doi/abs/10.1002/chem.201904053
Prithviraj, R., Ravikumar, M.J., Suthanthiram, B., Subbaraya, U. and Krishnamurthy, P., 2021. Genome-scale analyses of polyketide synthases in banana: Phylogenetics and expression profiling forecast their candidacy in specialized metabolism. Gene, 778, p.145472. Retrieved from: https://www.sciencedirect.com/science/article/pii/S0378111921000664
Rashid, M., 2021. Targeting the Peroxisomes for Synthesizing Polyketides by Type-III PKSs Enzymes in Tobacco and Petunia. Retrieved from: https://helda.helsinki.fi/handle/10138/331548
Robertsen, H.L. and Musiol-Kroll, E.M., 2019. Actinomycete-derived polyketides as a source of antibiotic and lead structures for developing new antibacterial drugs. antibiotic, 8(4), p.157. Retrieved from: https://www.mdpi.com/538174
Robey, M.T., Caesar, L.K., Drott, M.T., Keller, N.P. and Kelleher, N.L., 2021. An interpreted atlas of biosynthetic gene clusters from 1,000 fungal genomes. Proceedings of the National Academy of Sciences, 118(19). Retrieved from: https://www.pnas.org/content/118/19/e2020230118.short
Rust, M., Helfrich, E.J., Freeman, M.F., Nanudorn, P., Field, C.M., Rückert, C., Kündig, T., Page, M.J., Webb, V.L., Kalinowski, J. and Sunagawa, S., 2020. A multiproducer microbiome generates chemical diversity in the marine sponge Mycale Hentschel. Proceedings of the National Academy of Sciences, 117(17), pp.9508-9518. Retrieved from: https://www.pnas.org/content/117/17/9508.short
Saldívar-González, F.I., Aldas-Bulos, V.D., Medina-Franco, J.L. and Plisson, F., 2022. Natural product drug discovery in the artificial intelligence era. Chemical Science, 13(6), pp.1526-1546. Retrieved from: https://pubs.rsc.org/en/content/articlehtml/2022/sc/d1sc04471k
Scott, T.A., and Piel, J., 2019. The hidden enzymology of bacterial natural product biosynthesis. Nature Reviews Chemistry, 3(7), pp.404-425. Retrieved from: https://www.nature.com/articles/s41570-019-0107-1
Silva, S.G., Blom, J., Keller?Costa, T. and Costa, R., 2019. Comparative genomics reveals complex natural product biosynthesis capacities and carbon metabolism across host?associated and free?living Aquimarina (Bacteroidetes, Flavobacteriaceae) species. Environmental Microbiology, 21(11), pp.4002-4019. Retrieved from: https://sfamjournals.onlinelibrary.wiley.com/doi/abs/10.1111/1462-2920.14747
Smith, F.J.D., Kreuser?Genis, I.M., Jury, C.S., Wilson, N.J., Terron?Kwiatowski, A. and Zamiri, M., 2019. Novel and recurrent mutations in keratin cause epidermolytic ichthyosis and palmoplantar keratoderma. Clinical and experimental dermatology, 44(5), pp.528-534. Retrieved from: https://onlinelibrary.wiley.com/doi/abs/10.1111/ced.13800
Steele, L., Tawfik, S.S. and O’Toole, E.A., 2020. The Proteolytic Network in Palmoplantar Keratoderma: SERPINA12 Joins the Family. Journal of Investigative Dermatology, 140(11), pp.2111-2113. Retrieved from: https://www.sciencedirect.com/science/article/pii/S0022202X2031962X
Tavanti, M., Hosford, J., Lloyd, R.C. and Brown, M.J., 2021. Recent Developments and Challenges for the Industrial Implementation of Polyphosphate Kinases. ChemCatChem, 13(16), pp.3565-3580. Retrieved from: https://chemistry-europe.onlinelibrary.wiley.com/doi/abs/10.1002/cctc.202100688
Torres, J.P., Lin, Z., Winter, J.M., Krug, P.J. and Schmidt, E.W., 2020. Animal biosynthesis of complex polyketides in a photosynthetic partnership. Nature communications, 11(1), pp.1-12. Retrieved from: https://www.nature.com/articles/s41467-020-16376-5
Ueoka, R., Bhushan, A., Probst, S.I., Bray, W.M., Lokey, R.S., Linington, R.G. and Piel, J., 2018. Genome?Based Identification of a Plant?Associated Marine Bacterium as a Rich Natural Product Source. Angewandte Chemie, 130(44), pp.14727-14731. Retrieved from: https://onlinelibrary.wiley.com/doi/abs/10.1002/ange.201805673
Ueoka, R., Bortfeld?Miller, M., Morinaka, B.I., Vorholt, J.A. and Piel, J., 2018. Toblerols: Cyclopropanol?containing polyketide modulators of antibiosis in Methylobacteria. Angewandte Chemie, 130(4), pp.989-993. Retrieved from: https://onlinelibrary.wiley.com/doi/abs/10.1002/ange.201709056
Yoneda, K., Kubo, A., Nomura, T., Ishida?Yamamoto, A., Suga, Y., Akiyama, M., Kanazawa, N., Hashimoto, T., and Committee on Guidelines for the Management of PPKs, 2021. Japanese guidelines for the management of palmoplantar keratoderma. The Journal of Dermatology, 48(8), pp.e353-e367. Retrieved from: https://onlinelibrary.wiley.com/doi/abs/10.1111/1346-8138.15850
Zhang, J., Sun, Y., Wang, Y., Chen, X., Xue, L., Zhang, J., Zhu, X., Duan, Y. and Yan, X., 2021. Genome mining of novel rubiginous from Streptomyces sp. CB02414 and characterization of the post-PKS modification steps in ubiquinone biosynthesis. Microbial cell factories, 20(1), pp.1-14. Retrieved from: https://link.springer.com/article/10.1186/s12934-021-01681-5
Zhang, L., Yue, Q., Wang, C., Xu, Y. and Molnár, I., 2020. Secondary metabolites from hypocrealean entomopathogenic fungi: genomics as a tool to elucidate the encoded parvo. Natural product reports, 37(9), pp.1164-1180. Retrieved from: https://pubs.rsc.org/en/content/articlehtml/2020/np/d0np00007h
Order an Essay Now & Get These Features For Free:
Turnitin Report
Formatting
Title Page
Citation
Outline
